Eva Bengtsson
61 – 70 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Induction of T helper 2 responses against human Apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
(2014) In Cardiovascular Research
- Contribution to journal › Article
- 2013
-
Mark
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice.
- Contribution to journal › Article
- 2012
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
- Contribution to journal › Article
-
Mark
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr(-/-) Mice Compared to Nondiabetic LDLr(-/-) Mice.
- Contribution to journal › Article
-
Mark
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation
- Contribution to journal › Article
- 2011
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
- Contribution to journal › Article
- 2010
-
Mark
Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe(-/-) mice.
- Contribution to journal › Article
- 2009
-
Mark
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
- Contribution to journal › Article
-
Mark
Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
- Contribution to journal › Article
-
Mark
Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
- Contribution to journal › Article
